349
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience

, , &
Pages 899-904 | Received 15 Apr 2019, Accepted 06 Jun 2019, Published online: 16 Jun 2019

References

  • Strunk H, Marinova M. Transjugular intrahepatic portosystemic shunt (TIPS): pathophysiologic basics, actual indications and results with review of the literature. Rofo. 2018;190:701–711.
  • Rössle M. TIPS: 25years later. J Hepatol. 2013;59:1081–1093.
  • Astrup LB, Grønbaek H, Redsted S, et al. [TIPS–transjugular intrahepatic portosystemic shunt. Experiences from a recently started center]. Ugeskr Laeger. 2003;165:443–446.
  • Grønbaek H, Astrup LB, Nielsen DT, et al. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis]. Ugeskr Laeger. 2003;165:439–442.
  • Casado M, Bosch J, García-Pagán JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296–1303.
  • Domagk D, Patch D, Dick R, et al. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study. Cardiovasc Intervent Radiol. 2002;25:506–512.
  • Hausegger KA, Karnel F, Georgieva B, et al. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol. 2004;15:239–248.
  • Tripathi D, Helmy A, Macbeth K, et al. Ten years’ follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre. Eur J Gastroenterol Hepatol. 2004;16:9–18.
  • Maleux G, Nevens F, Wilmer A, et al. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol. 2004;14:1842–1850.
  • Kochar N, Tripathi D, Ireland H, et al. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut. 2006;55:1617–1623.
  • Thalheimer U, Leandro G, Samonakis DN, et al. TIPS for refractory ascites: a single-centre experience. J Gastroenterol. 2009;44:1089–1095.
  • Lodato F, Berzigotti A, Lisotti A, et al. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience. Scand J Gastroenterol. 2012;47:1494–1500.
  • Qin JP, Jiang MD, Tang W, et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center. World J Gastroenterol. 2013;19:8085–8092.
  • Kim SK, Lee KA, Sauk S, et al. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices. Korean J Radiol. 2017;18:345–354.
  • Tang Y, Zheng S, Yang J, et al. Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: a retrospective study of 182 cirrhotic portal hypertension patients. Medicine (Baltimore). 2017;96:e8678.
  • Routhu M, Safka V, Routhu SK, et al. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS). Ann Hepatol. 2017;16:140–148.
  • Jepsen P, Vilstrup H, Andersen PK. The clinical course of cirrhosis: the importance of multistate models and competing risks analysis. Hepatology. 2015;62:292–302.
  • Lauridsen MM, Thiele M, Kimer N, et al. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis. 2013;28:231–234.
  • Bai M, Qi XS, Yang ZP, et al. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014;20:2704–2714.
  • Qi X, Jia J, Bai M, et al. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a meta-analysis. J Clin Gastroenterol. 2015;49:495–505.
  • Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.
  • Fagiuoli S, Bruno R, Debernardi Venon W, et al. Consensus conference on TIPS management: techniques, indications, contraindications. Dig Liver Dis. 2017;49:121–137.
  • Piecha F, Radunski U, Ozga A-K, et al. Ascites control by TIPS is more succesful in patients with a lower paracentesis frequency and associated with improved survival. JHEP Reports. 2019. DOI:10.1016/j.jhepr.2019.04.001.
  • Gupta AC, Wang W, Shah C, et al. Added value of covered stents in transjugular intrahepatic portosystemic shunt: a large single-center experience. Cardiovasc Intervent Radiol. 2017;40:1723–1731.
  • Luo X, Zhao M, Wang X, et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PLoS One. 2019;14:e0212658.
  • Wu Q, Jiang J, He Y, et al. Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent. Exp Ther Med. 2013;5:263–266.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.